About
Samphire Neuroscience is a women's health technology company that bridges neuroscience and cycle health. Their flagship products — the Nettle™ and Lutea™ neurostimulation headbands — deliver 20-minute, drug-free sessions a few days per month to help women find relief from hormonal symptoms including pain, mood disruption, brain fog, and anxiety. Results are supported by a clinically validated, double-blind study (WIND 2024), with the majority of users reporting improvement within three cycles. The Samphire App complements the hardware by providing whole-body menstrual cycle management, smart cycle predictions, and personalized planning tools. The platform addresses a broad range of conditions: endometriosis, PMS, PMDD, dysmenorrhea, perimenopause, neurodiversity intersections, sleep disruption, and emotional regulation. Samphire positions itself for individual users, clinicians integrating neurostimulation into patient care, and employers looking to support workforce wellbeing. The devices are compatible with most existing treatments and designed for home use, removing barriers to access. The company collaborates with research institutions and healthcare professionals to close the gender health knowledge gap, making it a science-first platform for anyone looking to better understand and manage the relationship between the brain and the menstrual cycle.
Key Features
- Neurostimulation Devices (Nettle™ & Lutea™): Wearable headbands that deliver clinically validated neurostimulation sessions to relieve pain, mood disruption, and hormonal symptoms — no drugs or hormones required.
- Samphire App – Cycle Management: A whole-body menstrual cycle management app that tracks symptoms, provides smart cycle predictions, and helps users plan around their hormonal patterns.
- Smart Cycle Predictions: AI-powered predictions that anticipate cycle phases and symptom windows, enabling proactive management of energy, mood, focus, and pain.
- Clinically Validated & Research-Backed: All solutions are supported by a double-blind clinical study (WIND 2024) and decades of neuroscience research into how the brain shapes the menstrual cycle.
- Cross-Condition Coverage: Addresses a wide spectrum of women's health conditions including endometriosis, PMS, PMDD, dysmenorrhea, perimenopause, neurodivergence, sleep, and emotional wellbeing.
Use Cases
- Managing PMS and PMDD symptoms naturally without pharmaceuticals or hormonal therapy
- Reducing chronic menstrual pain and cramps caused by dysmenorrhea or endometriosis
- Supporting women through the hormonal transition of perimenopause with non-invasive tools
- Employers building women's health workplace wellness programs to reduce absenteeism and improve productivity
- Clinicians integrating adjunct neurostimulation therapy into patient treatment plans for hormonal conditions
Pros
- Drug and Hormone-Free: Provides effective symptom relief without pharmaceuticals or hormones, making it accessible to women who cannot or prefer not to use medication.
- Clinically Tested: Backed by a double-blind, clinically validated study, offering a level of scientific rigor rare in the women's wellness space.
- Compatible With Existing Treatments: Designed to integrate alongside other therapies, allowing users and clinicians to add neurostimulation without disrupting current care plans.
- Home Use & Accessible: 20-minute sessions designed for home use reduce the need for clinic visits, making ongoing treatment practical and low-friction.
Cons
- Hardware Purchase Required: Effective use requires purchasing physical neurostimulation devices, which may represent a significant upfront cost for some users.
- Niche Audience: Exclusively focused on women's menstrual and hormonal health, limiting its applicability outside this specific demographic and set of conditions.
- Requires Consistent Use: Best results come from regular sessions across multiple cycles, requiring sustained commitment before the full benefit is realized.
Frequently Asked Questions
The Nettle™ and Lutea™ headbands deliver non-invasive neurostimulation to targeted areas of the brain. Sessions last 20 minutes and are used a few days per month. The technology is grounded in decades of research on how the brain influences hormonal and menstrual processes.
Yes. Samphire's neurostimulation solutions are designed to be compatible with most existing treatments, including medications and therapies. Clinicians can integrate them into patient care without replacing current protocols.
Samphire addresses a broad range of conditions including endometriosis, PMS, PMDD, dysmenorrhea (menstrual cramps), perimenopause, neurodivergence, sleep disruption, mood instability, and stress and anxiety related to the menstrual cycle.
Based on the WIND 2024 clinical study, the majority of users report improvement within three menstrual cycles of regular use.
Samphire offers a 90-day risk-free return policy on the Nettle™ device, allowing users to try the product and return it if they are not satisfied.